Copeptin in Differentiation of Polyuria and Polydipsia
2 other identifiers
observational
50
1 country
1
Brief Summary
The differential diagnosis of patients with polyuria/ polydipsia is often complex, but important for the therapeutic strategy. Challenging is in particular the clinical differentiation between patients with a partial Diabetes insipidus centralis and patients with primary polydipsia as underlying disease, because both groups are associated with similar urinary osmolalities. The determination of plasma arginine vasopressin is unusual in this context, since measurement of AVP is not reliably. C-terminal ProVasopressin (copeptin) is secreted stoichiometrically with AVP from the neurohypophysis, but has a longer half life in the circulation, and is thus easier to measure. Therefore, the investigators will analyze in that study the diagnostic utility of plasma copeptin in the differential diagnosis of polyuria and polydipsia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Mar 2008
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2008
CompletedFirst Submitted
Initial submission to the registry
January 25, 2010
CompletedFirst Posted
Study publicly available on registry
January 26, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2010
CompletedApril 25, 2011
November 1, 2010
2.7 years
January 25, 2010
April 22, 2011
Conditions
Keywords
Study Arms (1)
Primary Polydip, D. insipidus
Eligibility Criteria
Healthy probands Patients with diabetes insipdus centralis totalis/ partials Patients with diabetes insipidus renalis Patients with primary polydipsia
You may qualify if:
- Patients with polydipsia/ polyuria, with indication for performing a deprivation test
- \> 18 years
You may not qualify if:
- dDAVP during the last 14d
- pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Wuerzburglead
- Dr. Carson Liu Med Corp.collaborator
Study Sites (1)
Univ Hospital Wuerzburg
Würzburg, Bavaria, 97080, Germany
Related Publications (1)
Fenske W, Quinkler M, Lorenz D, Zopf K, Haagen U, Papassotiriou J, Pfeiffer AF, Fassnacht M, Stork S, Allolio B. Copeptin in the differential diagnosis of the polydipsia-polyuria syndrome--revisiting the direct and indirect water deprivation tests. J Clin Endocrinol Metab. 2011 May;96(5):1506-15. doi: 10.1210/jc.2010-2345. Epub 2011 Mar 2.
PMID: 21367924DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
January 25, 2010
First Posted
January 26, 2010
Study Start
March 1, 2008
Primary Completion
November 1, 2010
Study Completion
November 1, 2010
Last Updated
April 25, 2011
Record last verified: 2010-11